CN Patent
CN109748944B — 5’-脱氧-5’-异丙基取代氨基核苷类化合物、其制备方法和用途
Assigned to Shanghai Institute of Materia Medica of CAS · Expires 2021-12-10 · 4y expired
What this patent protects
本发明公开了通式7所示的5’‑脱氧‑5’‑异丙基取代氨基核苷类化合物,该类化合物7的制备方法,以及该类化合物7作为中间体在制备5’‑脱氧‑5’‑多取代氨基核苷类化合物1中的应用。
USPTO Abstract
本发明公开了通式7所示的5’‑脱氧‑5’‑异丙基取代氨基核苷类化合物,该类化合物7的制备方法,以及该类化合物7作为中间体在制备5’‑脱氧‑5’‑多取代氨基核苷类化合物1中的应用。
Drugs covered by this patent
- Veklury (remdesivir) · Gilead Sciences
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.